Ranbaxy gets a reprieve in generic case-Pharmaceuticals-Healthcare/Biotech-News By Industry-News-The Economic Times
Links shared publicly online about this topic.
- 1,290total visits
Ranbaxy gets a reprieve in generic case-Pharmaceuticals-Healthcare/Biotech-News By Industry-News-The Economic Times
economictimes.indiatimes.com —
The Delhi High Court has turned down a plea by US pharma major Bristol-Myers Squibb (BMS) to ban India’s Ranbaxy Laboratories from launching a generic, or copycat, version of its patented hepatitis B drug Baraclude.
View full resource at economictimes.indiatimes.com
Tags: Liver Condition, Hepatitis, Hepatitis B, Hepatitis B Medication, Drug, Pharma, Baraclude, Bristol-Myers Squibb
Most Recently Shared on March 25, 2010 at 1:52 am By:
The Economic Times: Ranbaxy gets a reprieve in generic case in #India. http://bit.ly/cSYjed
Advertisement
